ARCHIVES

Why Four? NCI Official Challenged To Explain Rational For Proposed Number Of Groups

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Hammer, ACS Agree n Procedures for Award Of Facilities Survey Contract

March 30, 1984

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

May 2, 2003

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

June 4, 1999

In Brief: Switch To Grants Did Not hurt Virus Research, Watson says; The Field Is Healthy, Well Funded

October 2, 1981